Informazioni generali
  • Categoria della malattia Cancro del pancreas , Chirurgia / intervento / operazione (BASEC)
  • Stato di reclutamento Sconosciuto (BASEC/ICTRP)
  • Luogo dello studio
    Winterthur
    (BASEC)
  • Responsabile dello studio PD Dr. med. Patryk Kambakamba patryk.kambakamba@ksw.ch (BASEC)
  • Fonte dati BASEC: Importato da 08.01.2025 ICTRP: N/A
  • Ultimo aggiornamento 08.01.2025 14:16
HumRes65805 | SNCTP000006074 | BASEC2022-00983

The effect of Platelet Rich Plasma (PRP) on the postoperative course after pancreatic surgeries

  • Categoria della malattia Cancro del pancreas , Chirurgia / intervento / operazione (BASEC)
  • Stato di reclutamento Sconosciuto (BASEC/ICTRP)
  • Luogo dello studio
    Winterthur
    (BASEC)
  • Responsabile dello studio PD Dr. med. Patryk Kambakamba patryk.kambakamba@ksw.ch (BASEC)
  • Fonte dati BASEC: Importato da 08.01.2025 ICTRP: N/A
  • Ultimo aggiornamento 08.01.2025 14:16

Descrizione riassuntiva dello studio

In various medical fields, Platelet Rich Plasma (PRP) is described as having a "healing" effect. Approximately 5-10 ml of blood is taken from the patient and isolated using a centrifugation system to obtain the PRP. This is routinely injected locally, for example, in sports injuries, to accelerate healing. In visceral surgery, we also rely on optimal healing after surgeries in the abdominal cavity. Particularly, surgeries on the pancreas are especially prone to complications due to the softness of the organ and aggressive digestive enzymes (amylase). Therefore, it would be of particular interest to develop measures that improve the postoperative healing of the pancreas. In this study, we investigate for the first time the effect of PRP on healing after pancreatic surgeries. In the operating room, 10 ml of blood is taken, and the PRP is obtained from your own blood. Your PRP will then be used to cover the severed area of the pancreas during the operation. No further interventions will be required afterwards. In case of postoperative complications, these will be anonymized and recorded in our database at the Cantonal Hospital of Winterthur (KSW). The complications will be compared with patients who have previously undergone pancreatic surgery at KSW without the addition of PRP.

(BASEC)

Intervento studiato

In the operating room, approximately 10 ml of blood is taken. From the blood, the platelet-rich plasma (PRP) is isolated using the ACP system from Arthrex. The ACP system is routinely used for medical applications at KSW. The PRP is then applied to the severed area of the pancreas during the operation.

(BASEC)

Malattie studiate

Various disease patterns and especially types of cancer necessitate surgeries on the pancreas (pankreas). Inevitably, pancreatic tissue is severed. This can lead to postoperative leaks of the pancreatic duct, allowing pancreatic fluid to enter the abdominal cavity. These leaks are referred to as pancreatic fistulas and occur in up to 30% of cases. These fistulas are the main reason for severe complications after pancreatic surgeries. In this study, we investigate factors from the patient's own blood that may improve the healing of the pancreas and thus reduce the rate of fistulas. For this purpose, blood is taken in the operating room, and the fraction rich in platelets (Platelet Rich Plasma, PRP) is isolated. This platelet-enriched fraction (PRP) is then applied to the pancreas. The extraction of PRP is a standardized procedure and is routinely used, for example, in plastic surgery, orthopedics, and rheumatology.

(BASEC)

Criteri di partecipazione
- All patients with pancreatic head resections - All patients with left pancreatic resections if fulfilled: - >18 years - signed informed consent (BASEC)

Criteri di esclusione
- <18 years - no signed informed consent (BASEC)

Luogo dello studio

Winterthur

(BASEC)

non disponibile

Sponsor

non disponibile

Contatto per ulteriori informazioni sullo studio

Persona di contatto in Svizzera

PD Dr. med. Patryk Kambakamba

0754385239

patryk.kambakamba@ksw.ch

(BASEC)

Informazioni scientifiche

non disponibile

Nome del comitato etico approvante (per studi multicentrici solo il comitato principale)

Commissione etica Zurigo

(BASEC)

Data di approvazione del comitato etico

06.01.2023

(BASEC)


ID di studio ICTRP
non disponibile

Titolo ufficiale (approvato dal comitato etico)
non disponibile

Titolo accademico
non disponibile

Titolo pubblico
non disponibile

Malattie studiate
non disponibile

Intervento studiato
non disponibile

Tipo di studio
non disponibile

Disegno dello studio
non disponibile

Criteri di inclusione/esclusione
non disponibile

non disponibile

Endpoint primari e secondari
non disponibile

non disponibile

Data di registrazione
non disponibile

Inclusione del primo partecipante
non disponibile

Sponsor secondari
non disponibile

Contatti aggiuntivi
non disponibile

ID secondari
non disponibile

Risultati-Dati individuali dei partecipanti
non disponibile

Ulteriori informazioni sullo studio
non disponibile

Risultati dello studio

Riepilogo dei risultati

non disponibile

Link ai risultati nel registro primario

non disponibile